Pioglitazone
Product Images NDC 50090-4780

3 FDA label images from A-s Medication Solutions · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Pioglitazone (NDC 50090-4780). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Image 1)

Chemical Structure (Image 1)
Chemical structure of pioglitazone hydrochloride, showing the molecular arrangement including a pyridine ring, a thiazolidinedione ring, and associated functional groups.*
FDA Label Image

Figure 1 (Image 2)

Figure 1 (Image 2)
A line graph depicting mean values over 26 weeks for four groups: placebo, 15 mg, 30 mg, and 45 mg. The x-axis represents time in weeks, and the y-axis represents the mean. Each group is represented by a different symbol and color, with a legend below the x-axis. The placebo group is marked with blue crosses, 15 mg with red squares, 30 mg with green triangles, and 45 mg with black diamonds.*
FDA Label Image

Label Image (Lbl500904780)

Label Image (Lbl500904780)
Pioglitazone 15 mg tablet bottle label from A-S Medication Solutions, NDC 50090-4780-1. The label indicates each tablet contains 15 mg of pioglitazone hydrochloride, USP equivalent to 15 mg of pioglitazone. The bottle contains 90 tablets and instructs storage at 68 to 77 degrees Fahrenheit, protecting from moisture and humidity.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.